For a holistic health economics study, it is not enough to simply measure resource use and corresponding costs and similar criteria. The impact of health technologies on patient reported outcomes (PROs), including quality of life, has to be considered.
Healthcare is an emotive issue and purchasing decisions cannot always be made purely on clinical outcome and costing criteria. To consider the impact of a technology on a patient’s quality of life in ameliorating the impact of a disease, is to consider health outcomes from a patient’s preferential perspective. CATALYST has considerable experience in designing, disseminating and delivering quality of life studies. Using standard gamble and time trade-off methodologies in addition to generic and disease-specific quality of life instruments, CATALYST has evaluated the outcomes in patients receiving different treatments in diverse diseases.